TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| A Perfect Storm Brewing for Plasma Stocks EP Vantage submits:Baxter International (BAX) started it with a profit warning last week, saying that its blood plasma revenues would not grow by the expected mid-single digits for 2010 and instead would decline by a damaging mid-single digits. The group fashionably included US healthcare reform as one of the reasons for the dip, but the news of its difficulties soon caused the other main players in the plasma sector to rapidly start hemorrhaging value. While Baxter finished last week with a 17% decline in its shares to a 10-month low, the likes of Talecris Biotherapeutics (TLCR) dipped 11%, Grifols (GIFLF.PK) was down by 12% and despite CSL (CMXHY.PK) protesting it would not be revising its earnings guidance, its shares also finished the week 8% lower. The falls are perhaps so steep because, as can be seen from the table below, many had been expecting the good old days in the plasma and immune globulin market to continue and growth in the sector to continue at roughly 7% over the next seven years.Complete Story » seekingalpha.com |
J&J Bought Defective Motrin A Johnson & Johnson contractor last year told employees to act like customers when removing a defective painkiller from retail stores. The medicine was formally recalled several months later at the urging of the FDA. online.wsj.com |
MEDTOX Scientific Announces Second Quarter Conference Call (GlobeNewswire) ST. PAUL, Minn. -- MEDTOX Scientific, Inc. , announced today that it will hold a teleconference to discuss second quarter results on Thursday, July 15, at 9:30 a.m. Central Time . During the conference call, the Company may discuss and answer questions concerning business and financial developments and trends. us.rd.yahoo.com |
Firms, Unions to Draw Health Funds Almost 2,000 employers and unions will be allowed to submit their retirees' medical bills for reimbursement by a $5 billion government fund, the Obama administration will disclose Tuesday, suggesting the fund will be spread widely but thinly. online.wsj.com |
Justice Department Tries to Intervene in Case Against Pfizer The Justice Department is trying to take the lead in a lawsuit accusing Pfizer's Wyeth unit of improperly promoting an organ-transplant drug for unauthorized uses and paying illegal kickbacks to doctors. online.wsj.com |